215
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil

, , , , &
Pages 780-785 | Received 25 Mar 2013, Accepted 22 May 2013, Published online: 23 Jul 2013

References

  • Heath PT, Schuchat A. Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol 2007;21:411–24.
  • Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease. Revised Guidelines from CDC, 2010. MMWR Morb Mortal Wkly Rep. 2010;59:1–32.
  • Martins ER, Andreu A, Correia P, Juncosa T, Bosch J, Ramirez M, et al. Group B streptococci causing neonatal infections in Barcelona are a stable clonal population: 18-year surveillance. J Clin Microbiol 2011;49:2911–8.
  • Verani JR, Schrag SJ. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 2010;37:375–92.
  • Borger IL, d’Oliveira RE, Castro AC, Mondino SS. Streptococcus agalactiae em gestantes: prevalência de colonização e avaliação da susceptibilidade aos antimicrobianos. Rev Bras Ginecol Obstet 2005;27:575–9.
  • Costa AL, Lamy Filho F, Chen MB, Brito LM, Lamy ZC, Andrade KL. Prevalência da colonização por estreptococos do grupo B em gestantes atendidas em maternidade pública da região nordeste do Brasil. Rev Bras Ginecol Obstet 2008;30:274–80.
  • Kimura K, Suzuki S, Wachino J, Kurokawa H, Yamane K, Shibata N, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008;52:2890–7.
  • Dahesh S, Hensler MJ, Van Sorge NM, Gertz RE Jr, Schrag S, Nizet V, et al. Point mutation in the Group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother 2008; 52:2915–8.
  • Corrêa AB, Silva LG, Pinto TC, Oliveira IC, Fernandes FG, Costa NS, et al. The genetic diversity and phenotypic characterisation of Streptococcus agalactiae isolates from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2011;106:1002–6.
  • Arbazua F, Arias A, García P, Ralph C, Cerda J, Riedel I, et al. Aumento de resistencia de Streptococcus agalactiae vaginal–anal en el tercer trimestre de gestacíon a eritromicina y clindamicina al cabo de una década tamizaje universal. Rev Chil Infect 2011;28:334–7.
  • Duarte RS, Bellei BC, Miranda OP, Brito MA, Teixeira LM. Phenotypic and molecular characteristics of Streptococcus agalactiae isolates recovered from milk of dairy cows in Brazil. J Clin Microbiol 2004;42:4214–22.
  • Poyart C, Tazi A, Réglier-Poupet H, Billoët A, Tavares N, Raymond J, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007;45:1985–8.
  • Savoia D, Gottimer C, Crocilla C, Zucca M. Streptococcus agalactiae in pregnant women: phenotypic and genotypic characters. J Infect 2008;56:120–5.
  • Dmitriev A, Shakleina E, Tkáciková L, Mikula I, Totolian A. Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci. Folia Microbiol 2002; 47:291–5.
  • Manning SD, Ki M, Marrs CF, Kugeler KJ, Borchardt SM, Baker CJ, et al. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis 2006; 6:116.
  • Hannoun A, Shehab A, Khairallah MT, Sabra A, Abi-Rached R, Bazi T, et al. Correlation between group B streptococcal genotypes, their antimicrobial resistance profiles and virulence genes among pregnant women in Lebanon. Int J Microbiol 2009; doi: 10.1155/2009/796512
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. M100-S21. Wayne, PA: CLSI; 2011.
  • Murayama SY, Seki C, Sakata H, Sunaoshi K, Nakayama E, Iwata S, et al. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother 2009;53:2650–3.
  • Perez-Trallero E, Montes M, Orden B, Tamayo E, Garcia-Arenzana J, Marimón J. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. J Clin Microbiol 2007;51:1228–33.
  • Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–9.
  • Boswihi SS, Udo EE, Al-Sweih N. Serotypes and antibiotic resistance in Group B Streptococcus isolated from patients at the Maternity Hospital, Kuwait. J Med Microbiol 2012;61:126–31.
  • Palmeiro JK, Dalla-Costa LM, Fracalanzza SE, Botelho AC, Nogueira KS, Scheffer MC, et al. Phenotypic and genotypic characterization of group B streptococcal isolates in Southern Brazil. J Clin Microbiol 2010;48:4397–408.
  • Pinheiro S, Radhouani H, Coelho C, Gonçalves A, Carvalho E, Carvalho JA, et al. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women. Microb Drug Resist 2009;15:121–4.
  • Maisey HC, Doran KS, Nizet V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med 2009; 10:e27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.